The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients

The aims of this project are:to develop and implement a national multimodality application for patients with bladder cancer that builds upon knowledge from the iBLAD study.to investigate how the app, containing PRO questions on symptoms and QoL, information for health care providers, and peer-to-peer advice, can provide more knowledge on symptoms, QoL, and the need for supportive care.to examine the usability of and patient satisfaction with the app using qualitative methods.

Inclusion Criteria:Patients with bladder cancer defined as both urothelial tract-, bladder- and urethral cancer initiating first or second-line standard therapy with either chemotherapy or immunotherapyAge ≥ 18 years,Performance status ≤ 2Ability to read DanishNo serious cognitive impairmentInformed consent.Exclusion Criteria:No smartphone,Dementia, mental alteration, or psychiatric disease that can compromise informed consent from the patient and/or adherence to the protocol and the monitoring of the trial.